In silico design of the multi-epitope vaccine for lung adenocarcinoma based on hub gene-derived neoantigens

Abstract Background Lung adenocarcinoma (LUAD) is the most prevalent and lethal subtype of non-small cell lung cancer (NSCLC), characterized by an unfavorable 5-year survival rate ranging from 10% to 20%. Neoantigen-based vaccine platforms show encouraging benefits for NSCLC patients. However, the v...

Descripció completa

Dades bibliogràfiques

Autors principals:	Shaoshuai Li, Minjia Huang, Liqiu Jia, Siyu Liu, Xueting Sun, Daxia Cai, Yanping Su, Minjiang Chen, Chenying Lu, Jiansheng Huang, Jianfei Tu, Jiansong Ji
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-03-01
Col·lecció:	BMC Cancer
Matèries:	Neoantigen Multi-epitope vaccine Hub gene Immunoinformatics Reverse vaccinology In silico
Accés en línia:	https://doi.org/10.1186/s12885-026-15765-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!